Guangqiang Jiang serves as the Chief Technology Officer at Axonics Modulation Technologies, Inc., where he leverages over 20 years of extensive experience in research and development within the medical device industry. As a co-founder of Axonics, Guangqiang has played a pivotal role in shaping the...
Guangqiang Jiang serves as the Chief Technology Officer at Axonics Modulation Technologies, Inc., where he leverages over 20 years of extensive experience in research and development within the medical device industry. As a co-founder of Axonics, Guangqiang has played a pivotal role in shaping the company’s innovative trajectory, particularly in the realm of sacral neuromodulation (SNM) products. His leadership in cross-functional teams has been instrumental in transforming groundbreaking concepts into market-ready solutions that address significant unmet medical needs.
Under his guidance, Axonics has successfully navigated complex product development cycles, ensuring that each phase—from pre-clinical studies to mechanical product design—meets the highest standards of quality and efficacy. Guangqiang's expertise in biomaterials and biotechnology has been crucial in developing novel devices that enhance patient outcomes and improve quality of life. He actively interfaces with key opinion leaders (KOLs) and external experts, fostering collaborations that drive innovation and expand the company’s research horizons.
In addition to leading product development initiatives, Guangqiang oversees Axonics' intellectual property portfolio, strategically directing IP activities to safeguard the company’s innovations. His commitment to compatibility labeling efforts for SNM products exemplifies his dedication to ensuring that Axonics remains at the forefront of industry standards and regulatory compliance. With a robust background in manufacturing and a passion for advancing medical technology, Guangqiang Jiang continues to be a driving force in the evolution of medical devices that make a meaningful impact on patient care.
